Trials / Conditions / Venezuelan Equine Encephalitis
Venezuelan Equine Encephalitis
3 registered clinical trials studyying Venezuelan Equine Encephalitis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers NCT07088822 | Medigen, Inc. | Phase 1 |
| Completed | VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults NCT03879603 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Withdrawn | Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vacc NCT00109304 | DynPort Vaccine Company LLC, A GDIT Company | Phase 1 |